When in a drug epidemic should the policy objective switch from use reduction to harm reduction?

DOI10.1016/j.ejor.2009.03.015zbMath1177.90264OpenAlexW2110921297MaRDI QIDQ1044171

Dagmar Wallner, Gernot Tragler, Gustav Feichtinger, Jonathan P. Caulkins

Publication date: 10 December 2009

Published in: European Journal of Operational Research (Search for Journal in Brave)

Full work available at URL: https://doi.org/10.1016/j.ejor.2009.03.015

zbMATH Keywords

controlepidemicshealthOR in societal problem analysisdrug policy

Mathematics Subject Classification ID

Epidemiology (92D30) Case-oriented studies in operations research (90B90) Medical applications (general) (92C50)

Related Items (2)

Needle exchange for controlling HIV spread under endogenous infectivity ⋮ Leading bureaucracies to the tipping point: an alternative model of multiple stable equilibrium levels of corruption

Cites Work

• Enforcement swamping: A positive-feedback mechanism in rates of illicit activity
• A dynamic model of drug initiation: Implications for treatment and drug control
• The transmission and persistence of ‘urban legends’: Sociological application of age‐structured epidemic models
• A New Product Growth for Model Consumer Durables
• Optimal Control of Drug Epidemics: Prevent and Treat—But Not at the Same Time?
• Optimal Dynamic Allocation of Treatment and Enforcement in Illicit Drug Control

This page was built for publication: When in a drug epidemic should the policy objective switch from use reduction to harm reduction?